Abstracts tagged "complement deficiency"

Abstract Number: 1766 • 2017 ACR/ARHP Annual Meeting
Increased Renal Damage in Hypocomplementemic Patients with ANCA- Associated Vasculitis
Lucila García¹, Claudia Elizabeth Pena², Mariana Pera³, Mercedes Garcia², Valeria Arturi³, Viviana Nagua¹, Rodrigo Aguila Maldonado², Ana Carolina Costi², Adriana Testi¹, Ariel Vulcano¹, Pierina Sansinanea¹, Martin Mamberti⁴, Maria Elena Bruzzone⁴, Carolina Barabani⁴ and Jimena Salomone⁴, ¹Rheumatology, HIGA General San Martin La Plata, la plata, Argentina, ²Rheumatology, HIGA General San Martin La Plata, La Plata, Argentina, ³HIGA General San Martin La Plata, la plata, Argentina, ⁴Nephrology, HIGA General San Martin La Plata, la plata, Argentina
Background/Purpose: The pauci-immune nature of typical lesions in ANCA associated vasculitis (AAV) has led to the belief that complement does not play a role in…
Abstract Number: 2813 • 2016 ACR/ARHP Annual Meeting
Risk of Renal Failure within 10 or 20 Years of SLE Diagnosis, By Patient Characteristics
Laurence S Magder¹, Erik Barr² and Michelle Petri³, ¹Epidemiology and Public Health, Division of Rheumatology, School of Medicine, Johns Hopkins University, Baltimore, MD, ²Epidemiology, University of Maryland, Baltimore, MD, ³Rheumatology Division, Johns Hopkins University School of Medicine, Baltimore, MD
Background/Purpose: Patients with systemic lupus erythematosus (SLE) are at elevated risk for lupus nephritis and ultimately renal failure. While some risk factors for renal…
Abstract Number: 3087 • 2015 ACR/ARHP Annual Meeting
Cell Bound Complement Activation Products in Multianalyte Assay with Algorithm Have Utility in Distinguishing Primary Fibromyalgia from Systemic Lupus Erythematosus
Daniel Wallace¹, Stuart L. Silverman², Derren Barken³, John Conklin⁴ and Thierry Dervieux⁵, ¹Cedars-Sinai/UCLA, Los Angeles, CA, ²OMC Clinical Research Center, Beverly Hills, CA, ³Exagen Diagnostics, Vista, CA, ⁴1261 Liberty Way Suite C, Exagen Diagnostics, Vista, CA, ⁵Research and Development, Exagen Diagnostics, Vista, CA
Background/Purpose : Our objective was to prospectively establish the performance characteristics of a cell bound complement activation products (CB-CAPS) in a multi-analyte assay with algorithm…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].